Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2009
08/27/2009US20090214555 Proteoglycan Splice Variants as Therapeutics and Diagnostics for Amyloid Diseases
08/27/2009US20090214551 High Affinity Hiv T Cell Receptors
08/27/2009US20090214550 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy
08/27/2009US20090214547 Binding member towards pneumolysin
08/27/2009US20090214542 Novel therapeutic targets in cancer
08/27/2009US20090214534 Bispecific Domain Antibodies Targeting Serum Albumin And GLP-1 Or PYY
08/27/2009US20090214530 MODIFIED CpG OLIGODEOXYNUCLEOTIDE WITH IMPROVED IMMUNOREGULATORY FUNCTION
08/27/2009US20090214524 Methods and compositions for regulating cell cycle checkpoints
08/27/2009US20090214515 Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins
08/27/2009US20090214513 Mammalian expression systems
08/27/2009US20090214510 Broad Spectrum Antiviral Compositions
08/27/2009US20090214508 Vegf-activated fas ligands
08/27/2009US20090214505 For treating an excess of a substrate for a hyaluronidase, such as reducing scar tissue
08/27/2009US20090214495 Vascular endothelial growth factor-d (vegf)-d and functionally fragments thereof for bone repairing
08/27/2009US20090214492 Isolated stromal cells for use in the treatment of diseases of the central nervous system
08/27/2009US20090214483 Progenitor Cells and Uses Thereof
08/27/2009US20090214480 Novel cancer antigen peptide and the use thereof
08/27/2009US20090214478 Method of treating ocular diseases by gene therapy
08/27/2009US20090214477 Human Marker Genes and Agents for Diagnosis, Treatment and Prophylaxis of Cardiovascular Disorders and Artherosclerosis
08/27/2009US20090214476 Novel mannose-specific adhesins and their use
08/27/2009US20090214463 Latent phase viral interleukin-10-(VII-10) and uses thereof
08/27/2009US20090214435 Recombinant vector expressing MDR1 shRNA and thymidine kinase and use thereof
08/27/2009US20090214431 Identification of ergothioneine transporter and therapeutic uses thereof
08/27/2009US20090214430 Polypeptide specifically bound to phosphatidylserine and the use thereof
08/27/2009US20090214428 Human Monoclonal Antibodies Against Hendra and Nipah Viruses
08/27/2009US20090214425 Tumor therapy with replication competent sindbis viral vectors
08/27/2009US20090214422 DNA encoding a novel RG1 polypeptide
08/27/2009DE102008010954A1 DNA-Vakzine zur Therapie und Prophylaxe von Gebärmutterhalskrebs und seinen prämalignen Vorstufen DNA vaccine for the therapy and prophylaxis of cervical cancer and its precursors premalignant
08/27/2009DE102008010693A1 Neue Matrixmaterialien, Verfahren zu ihrer Herstellung und ihre Verwendung in Verfahren zur Isolierung von Biomolekülen New matrix materials, to processes for their preparation and their use in methods for isolating biomolecules
08/27/2009DE102008010692A1 Neue Matrices, Verfahren zu ihrer Herstellung und ihre Verwendung in Verfahren zur Isolierung von Biomolekülen New matrices, process for their preparation and their use in methods for isolating biomolecules
08/27/2009DE102004059633B4 Promotoren und deren Verwendung Promoters and their use
08/27/2009DE10084502B4 Verfahren zur Reinigung von Nukleinsäure mit Siliciumcarbid A process for the purification of nucleic acid with silicon carbide
08/27/2009CA2844188A1 Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
08/27/2009CA2716375A1 Genetic alterations associated with autism and the autistic phenotype and methods of use thereof for the diagnosis and treatmemt of autism
08/27/2009CA2716343A1 Micro-rnas that modulate smooth muscle proliferation and differentiation and uses thereof
08/27/2009CA2716280A1 Biomarkers
08/27/2009CA2716210A1 Escherichia coli immunogens with improved solubility
08/27/2009CA2716183A1 Means for improving agrobiological traits in a plant by providing a plant cell comprising in its chloroplasts enzymatic activities for converting glycolate into malate
08/27/2009CA2715940A1 Oligopeptidic compounds and uses thereof
08/27/2009CA2715924A1 Optimisation of expression of parvoviral rep and cap proteins in insect cells
08/27/2009CA2715871A1 Method of nucleic acid recombination
08/27/2009CA2715790A1 Electroporation cuvette with spatially variable electric field
08/27/2009CA2715774A1 Detection and prognosis of lung cancer
08/27/2009CA2715765A1 Compositions for enhanced uptake of viral vectors in the myocardium
08/27/2009CA2715397A1 Nucleotide sequences and corresponding polypeptides conferring improved nitrogen use efficiency characteristics in plants
08/27/2009CA2714296A1 Humanized anti-c5ar antibodies
08/27/2009CA2714166A1 Vectors and yeast strains for protein production
08/27/2009CA2709907A1 Peptide derived from neurotensin receptor 3 and use thereof in the treatment of psychiatric diseases
08/27/2009CA2707796A1 Polypeptides having endoglucanase activity and polynucleotides encoding same
08/27/2009CA2707029A1 Simian subfamily c adenoviruses sadv-40, -31, and-34 and uses thereof
08/26/2009EP2093294A1 Nucleotide and protein sequences of Nogo genes and methods based thereon
08/26/2009EP2093293A2 G-Protein coupled receptors
08/26/2009EP2093292A2 Inhibition of specific histone deacetylase isoforms
08/26/2009EP2093291A1 A method for constructing an operon containing translationally coupled genes
08/26/2009EP2093290A1 Thrombin mutant
08/26/2009EP2093289A1 Knockout animal exhibiting anxiety-like behavior
08/26/2009EP2093288A1 Novel dipeptide-digesting enzyme, method of producing the same, method of assaying glycated protein by using the dipeptide-digesting enzyme and reagent composition to be used therein
08/26/2009EP2093287A1 Igg-binding peptide
08/26/2009EP2093286A1 Multi-chain eukaryotic display vectors and uses thereof
08/26/2009EP2093283A1 Means for improving agrobiological traits in a plant by providing a plant cell comprising in its chloroplasts enzymatic activities for converting glycolate into malate
08/26/2009EP2093282A1 Bilirubin oxidase mutant having thermal stability
08/26/2009EP2093281A1 Protein nanocarriers, process for obtaining them and applications
08/26/2009EP2093280A1 Cre-master mouse (mouse strain selectively lacking mast cells)
08/26/2009EP2093237A1 Cancer therapeutic agent comprising anti-hb-egf antibody as active ingredient
08/26/2009EP2093233A1 Novel compositions and methods in cancer
08/26/2009EP2092080A1 Diagnosis and treatment of t-cell acute lymphoblastic leukemia
08/26/2009EP2092078A1 Nuclease-resistant rna aptamer inhibiting replication of hepatitis c virus replicon
08/26/2009EP2092070A2 Ethanol production
08/26/2009EP2092069A2 Modified soluble fgf receptor fc fusions with improved biological activity
08/26/2009EP2092068A2 Optimized non-canonical zinc finger proteins
08/26/2009EP2092067A1 Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof
08/26/2009EP2092065A1 Antisense compounds
08/26/2009EP2092064A1 Method for purifying rna on a preparative scale by means of hplc
08/26/2009EP2092063A2 Meganuclease variants cleaving a dna target sequence from the hprt gene and uses thereof
08/26/2009EP2091966A2 Promoter construct
08/26/2009EP2091965A1 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides
08/26/2009EP2091962A2 Cells and methodology to generate non-segmented negative-strand rna viruses
08/26/2009EP2091611A2 New drug for treating gastric cancer
08/26/2009EP2091569A2 Targeted delivery of therapeutic agents with lyophilized matrices
08/26/2009EP2091568A2 Fusion proteins comprising a anti-inflammatory cytokine and an antigen for treatment of immune disorders
08/26/2009EP2091560A1 Feline vaccines against avian influenza
08/26/2009EP2091556A2 G protein coupled receptors and uses thereof
08/26/2009EP2091319A1 Herbicide-resistant sunflower plants and methods of use
08/26/2009EP1963510B1 Grg23 and grg51 genes conferring herbicide resistance
08/26/2009EP1934354A4 Methods for producing hybrid seed
08/26/2009EP1920054A4 Method for separating and purifying rna
08/26/2009EP1856267B1 Vectors comprising novel regulatory elements
08/26/2009EP1734814A4 Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase
08/26/2009EP1716233B1 Regulated stop codon readthrough
08/26/2009EP1694833B1 2-methyl-6-solanylbenzoquinone methyltransferase as target for herbicides
08/26/2009EP1648481B1 Viral vectors
08/26/2009EP1601694B1 Uses of il-23 antagonists; related reagents
08/26/2009EP1536840B1 Formulation for inwardly transferring nucleic acids into eucaryotic cells
08/26/2009EP1530584B1 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
08/26/2009EP1423428B1 Antibodies that block fgfr3 activation, methods of screening for and uses thereof
08/26/2009EP1379698B1 Mobility-modified nucleobase polymers and methods of using same
08/26/2009EP1299524B1 Human myeloma cell line
08/26/2009EP1297005B1 Immunisation against chlamydia pneumoniae
08/26/2009EP1296559A4 Protein expression profiling
08/26/2009EP1283675A4 Methods of modulating the activity of mura
1 ... 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 ... 4023